John Vavricka Transaction History

Date Transaction Value Shares Traded Form
Nov 03 2020
BUY
Conversion of derivative security
-
82,508
JV

John Vavricka

Chief Commercial Officer
Boston, MA

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Track Activities on AVIR